Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate

Br J Pharmacol. 2007 Nov;152(5):633-48. doi: 10.1038/sj.bjp.0707440. Epub 2007 Sep 10.

Abstract

Recent physiological, pharmacological and anatomical studies provide evidence that one of the main roles of the endocannabinoid system in the brain is the regulation of gamma-aminobutyric acid (GABA) and glutamate release. This article aims to review this evidence in the context of its implications for pain. We first provide a brief overview of supraspinal regulation of nociception, followed by a review of the evidence that the brain's endocannabinoid system modulates nociception. We look in detail at regulation of supraspinal GABAergic and glutamatergic neurons by the endocannabinoid system and by exogenously administered cannabinoids. Finally, we review the evidence that cannabinoid-mediated modulation of pain involves modulation of GABAergic and glutamatergic neurotransmission in key brain regions.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain / cytology
  • Brain / metabolism*
  • Cannabinoid Receptor Modulators / metabolism
  • Cannabinoid Receptor Modulators / physiology*
  • Glutamates / metabolism
  • Humans
  • Models, Biological
  • Neurons / metabolism*
  • Pain / metabolism*
  • Pain / physiopathology
  • Sciatic Neuropathy / metabolism
  • Sciatic Neuropathy / physiopathology
  • Sciatic Neuropathy / prevention & control
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Cannabinoid Receptor Modulators
  • Glutamates
  • gamma-Aminobutyric Acid